1 Study Coverage 1.1 Kidney/Renal Fibrosis Treatment Revenue in Kidney/Renal Fibrosis Treatment Business (2017-2022) & (US$ Million) Introduction 1.2 Global Kidney/Renal Fibrosis Treatment Outlook 2017 VS 2022 VS 2028 1.2.1 Global Kidney/Renal Fibrosis Treatment Market Size for the Year 2017-2028 1.2.2 Global Kidney/Renal Fibrosis Treatment Market Size for the Year 2017-2028 1.3 Kidney/Renal Fibrosis Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.3.1 The Market Share of United States Kidney/Renal Fibrosis Treatment in Global, 2017 VS 2022 VS 2028 1.3.2 The Growth Rate of Kidney/Renal Fibrosis Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4 Kidney/Renal Fibrosis Treatment Market Dynamics 1.4.1 Kidney/Renal Fibrosis Treatment Industry Trends 1.4.2 Kidney/Renal Fibrosis Treatment Market Drivers 1.4.3 Kidney/Renal Fibrosis Treatment Market Challenges 1.4.4 Kidney/Renal Fibrosis Treatment Market Restraints 1.5 Study Objectives 1.6 Years Considered 2 Kidney/Renal Fibrosis Treatment by Type 2.1 Kidney/Renal Fibrosis Treatment Market Segment by Type 2.1.1 Angiotensin II Receptor Blockers (ARBs) 2.1.2 Angiotensin Converting Enzyme (ACE) Inhibitors 2.1.3 Pirfenidone 2.1.4 Renin Inhibitors 2.1.5 Vasopeptidase Inhibitors 2.2 Global Kidney/Renal Fibrosis Treatment Market Size by Type (2017, 2022 & 2028) 2.3 Global Kidney/Renal Fibrosis Treatment Market Size by Type (2017-2028) 2.4 United States Kidney/Renal Fibrosis Treatment Market Size by Type (2017, 2022 & 2028) 2.5 United States Kidney/Renal Fibrosis Treatment Market Size by Type (2017-2028) 3 Kidney/Renal Fibrosis Treatment by Application 3.1 Kidney/Renal Fibrosis Treatment Market Segment by Application 3.1.1 Commercial/Private Hospitals 3.1.2 Public Health Hospitals 3.1.3 Clinics 3.1.4 Home Treatment 3.2 Global Kidney/Renal Fibrosis Treatment Market Size by Application (2017, 2022 & 2028) 3.3 Global Kidney/Renal Fibrosis Treatment Market Size by Application (2017-2028) 3.4 United States Kidney/Renal Fibrosis Treatment Market Size by Application (2017, 2022 & 2028) 3.5 United States Kidney/Renal Fibrosis Treatment Market Size by Application (2017-2028) 4 Global Kidney/Renal Fibrosis Treatment Competitor Landscape by Company 4.1 Global Kidney/Renal Fibrosis Treatment Market Size by Company 4.1.1 Top Global Kidney/Renal Fibrosis Treatment Companies Ranked by Revenue (2021) 4.1.2 Global Kidney/Renal Fibrosis Treatment Revenue by Player (2017-2022) 4.2 Global Kidney/Renal Fibrosis Treatment Concentration Ratio (CR) 4.2.1 Kidney/Renal Fibrosis Treatment Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Companies of Kidney/Renal Fibrosis Treatment in 2021 4.2.3 Global Kidney/Renal Fibrosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Kidney/Renal Fibrosis Treatment Headquarters, Revenue in Kidney/Renal Fibrosis Treatment Business (2017-2022) & (US$ Million) Type 4.3.1 Global Kidney/Renal Fibrosis Treatment Headquarters and Area Served 4.3.2 Global Kidney/Renal Fibrosis Treatment Companies Revenue in Kidney/Renal Fibrosis Treatment Business (2017-2022) & (US$ Million) Type 4.3.3 Date of International Companies Enter into Kidney/Renal Fibrosis Treatment Market 4.4 Companies Mergers & Acquisitions, Expansion Plans 4.5 United States Kidney/Renal Fibrosis Treatment Market Size by Company 4.5.1 Top Kidney/Renal Fibrosis Treatment Players in United States, Ranked by Revenue (2021) 4.5.2 United States Kidney/Renal Fibrosis Treatment Revenue by Players (2020, 2021 & 2022) 5 Global Kidney/Renal Fibrosis Treatment Market Size by Region 5.1 Global Kidney/Renal Fibrosis Treatment Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Kidney/Renal Fibrosis Treatment Market Size by Region (2017-2028) 5.2.1 Global Kidney/Renal Fibrosis Treatment Market Size by Region: 2017-2022 5.2.2 Global Kidney/Renal Fibrosis Treatment Market Size by Region (2023-2028) 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Kidney/Renal Fibrosis Treatment Market Size YoY Growth 2017-2028 6.1.2 North America Kidney/Renal Fibrosis Treatment Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Kidney/Renal Fibrosis Treatment Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Kidney/Renal Fibrosis Treatment Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Kidney/Renal Fibrosis Treatment Market Size YoY Growth 2017-2028 6.3.2 Europe Kidney/Renal Fibrosis Treatment Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Kidney/Renal Fibrosis Treatment Market Size YoY Growth 2017-2028 6.4.2 Latin America Kidney/Renal Fibrosis Treatment Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Kidney/Renal Fibrosis Treatment Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Kidney/Renal Fibrosis Treatment Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 Galectin Therapeutics 7.1.1 Galectin Therapeutics Company Details 7.1.2 Galectin Therapeutics Business Overview 7.1.3 Galectin Therapeutics Kidney/Renal Fibrosis Treatment Introduction 7.1.4 Galectin Therapeutics Revenue in Kidney/Renal Fibrosis Treatment Business (2017-2022) 7.1.5 Galectin Therapeutics Recent Development 7.2 Merck & Co. 7.2.1 Merck & Co. Company Details 7.2.2 Merck & Co. Business Overview 7.2.3 Merck & Co. Kidney/Renal Fibrosis Treatment Introduction 7.2.4 Merck & Co. Revenue in Kidney/Renal Fibrosis Treatment Business (2017-2022) 7.2.5 Merck & Co. Recent Development 7.3 F. Hoffman-La Roche Ltd. 7.3.1 F. Hoffman-La Roche Ltd. Company Details 7.3.2 F. Hoffman-La Roche Ltd. Business Overview 7.3.3 F. Hoffman-La Roche Ltd. Kidney/Renal Fibrosis Treatment Introduction 7.3.4 F. Hoffman-La Roche Ltd. Revenue in Kidney/Renal Fibrosis Treatment Business (2017-2022) 7.3.5 F. Hoffman-La Roche Ltd. Recent Development 7.4 Pfizer Inc. 7.4.1 Pfizer Inc. Company Details 7.4.2 Pfizer Inc. Business Overview 7.4.3 Pfizer Inc. Kidney/Renal Fibrosis Treatment Introduction 7.4.4 Pfizer Inc. Revenue in Kidney/Renal Fibrosis Treatment Business (2017-2022) 7.4.5 Pfizer Inc. Recent Development 7.5 InterMune Inc. 7.5.1 InterMune Inc. Company Details 7.5.2 InterMune Inc. Business Overview 7.5.3 InterMune Inc. Kidney/Renal Fibrosis Treatment Introduction 7.5.4 InterMune Inc. Revenue in Kidney/Renal Fibrosis Treatment Business (2017-2022) 7.5.5 InterMune Inc. Recent Development 7.6 ProMetic Life-Sciences Inc. 7.6.1 ProMetic Life-Sciences Inc. Company Details 7.6.2 ProMetic Life-Sciences Inc. Business Overview 7.6.3 ProMetic Life-Sciences Inc. Kidney/Renal Fibrosis Treatment Introduction 7.6.4 ProMetic Life-Sciences Inc. Revenue in Kidney/Renal Fibrosis Treatment Business (2017-2022) 7.6.5 ProMetic Life-Sciences Inc. Recent Development 7.7 La Jolla Pharmaceutical Company 7.7.1 La Jolla Pharmaceutical Company Company Details 7.7.2 La Jolla Pharmaceutical Company Business Overview 7.7.3 La Jolla Pharmaceutical Company Kidney/Renal Fibrosis Treatment Introduction 7.7.4 La Jolla Pharmaceutical Company Revenue in Kidney/Renal Fibrosis Treatment Business (2017-2022) 7.7.5 La Jolla Pharmaceutical Company Recent Development 7.8 Genzyme Corporation 7.8.1 Genzyme Corporation Company Details 7.8.2 Genzyme Corporation Business Overview 7.8.3 Genzyme Corporation Kidney/Renal Fibrosis Treatment Introduction 7.8.4 Genzyme Corporation Revenue in Kidney/Renal Fibrosis Treatment Business (2017-2022) 7.8.5 Genzyme Corporation Recent Development 7.9 BioLine Rx Ltd 7.9.1 BioLine Rx Ltd Company Details 7.9.2 BioLine Rx Ltd Business Overview 7.9.3 BioLine Rx Ltd Kidney/Renal Fibrosis Treatment Introduction 7.9.4 BioLine Rx Ltd Revenue in Kidney/Renal Fibrosis Treatment Business (2017-2022) 7.9.5 BioLine Rx Ltd Recent Development 8 Research Findings and Conclusion 9 Appendix 9.1 Research Methodology 9.1.1 Methodology/Research Approach 9.1.2 Data Source 9.2 Author Details 9.3 Disclaimer

List of Tables Table 1. Kidney/Renal Fibrosis Treatment Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028) Table 2. Kidney/Renal Fibrosis Treatment Market Trends Table 3. Kidney/Renal Fibrosis Treatment Market Drivers Table 4. Kidney/Renal Fibrosis Treatment Market Challenges Table 5. Kidney/Renal Fibrosis Treatment Market Restraints Table 6. Global Kidney/Renal Fibrosis Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Kidney/Renal Fibrosis Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Kidney/Renal Fibrosis Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Kidney/Renal Fibrosis Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Kidney/Renal Fibrosis Treatment Companies in Global Market, Ranking by Revenue (2021) Table 11. Global Kidney/Renal Fibrosis Treatment Revenue by Player, (US$ Million), 2017-2022 Table 12. Global Kidney/Renal Fibrosis Treatment Revenue Share by Player, 2017-2022 Table 13. Global Kidney/Renal Fibrosis Treatment Companies Market Concentration Ratio (CR5 and HHI) Table 14. Global Kidney/Renal Fibrosis Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney/Renal Fibrosis Treatment as of 2021) Table 15. Top Players of Kidney/Renal Fibrosis Treatment in Global Market, Headquarters and Area Served Table 16. Companies Revenue in Kidney/Renal Fibrosis Treatment Business (2017-2022) & (US$ Million) Type Table 17. Date of International Companies Enter into Kidney/Renal Fibrosis Treatment Market Table 18. Companies Mergers & Acquisitions, Expansion Plans Table 19. Top Kidney/Renal Fibrosis Treatment Players in United States Market, Ranking by Revenue (2021) Table 20. United States Kidney/Renal Fibrosis Treatment Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 21. United States Kidney/Renal Fibrosis Treatment Revenue Share by Players, 2020, 2021 & 2022 Table 22. Global Kidney/Renal Fibrosis Treatment Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 23. Global Kidney/Renal Fibrosis Treatment Market Size by Region (2017-2022) & (US$ Million) Table 24. Global Kidney/Renal Fibrosis Treatment Market Size Forecast by Region (2023-2028) & (US$ Million) Table 25. North America Kidney/Renal Fibrosis Treatment Sales in Value by Country (2017-2028) & (US$ Million) Table 26. Asia Pacific Kidney/Renal Fibrosis Treatment Sales in Value by Region (2017-2028) & (US$ Million) Table 27. Europe Kidney/Renal Fibrosis Treatment Sales in Value by Country (2017-2028) & (US$ Million) Table 28. Latin Americaa Kidney/Renal Fibrosis Treatment Sales in Value by Country (2017-2028) & (US$ Million) Table 29. Middle East and Africa Kidney/Renal Fibrosis Treatment Sales in Value by Country (2017-2028) & (US$ Million) Table 30. Galectin Therapeutics Company Details Table 31. Galectin Therapeutics Business Overview Table 32. Galectin Therapeutics Kidney/Renal Fibrosis Treatment Product Table 33. Galectin Therapeutics Revenue in Kidney/Renal Fibrosis Treatment Business (2017-2022) & (US$ Million) Table 34. Galectin Therapeutics Recent Development Table 35. Merck & Co. Company Details Table 36. Merck & Co. Business Overview Table 37. Merck & Co. Kidney/Renal Fibrosis Treatment Product Table 38. Merck & Co. Revenue in Kidney/Renal Fibrosis Treatment Business (2017-2022) & (US$ Million) Table 39. Merck & Co. Recent Development Table 40. F. Hoffman-La Roche Ltd. Company Details Table 41. F. Hoffman-La Roche Ltd. Business Overview Table 42. F. Hoffman-La Roche Ltd. Kidney/Renal Fibrosis Treatment Product Table 43. F. Hoffman-La Roche Ltd. Revenue in Kidney/Renal Fibrosis Treatment Business (2017-2022) & (US$ Million) Table 44. F. Hoffman-La Roche Ltd. Recent Development Table 45. Pfizer Inc. Company Details Table 46. Pfizer Inc. Business Overview Table 47. Pfizer Inc. Kidney/Renal Fibrosis Treatment Product Table 48. Pfizer Inc. Revenue in Kidney/Renal Fibrosis Treatment Business (2017-2022) & (US$ Million) Table 49. Pfizer Inc. Recent Development Table 50. InterMune Inc. Company Details Table 51. InterMune Inc. Business Overview Table 52. InterMune Inc. Kidney/Renal Fibrosis Treatment Product Table 53. InterMune Inc. Revenue in Kidney/Renal Fibrosis Treatment Business (2017-2022) & (US$ Million) Table 54. InterMune Inc. Recent Development Table 55. ProMetic Life-Sciences Inc. Company Details Table 56. ProMetic Life-Sciences Inc. Business Overview Table 57. ProMetic Life-Sciences Inc. Kidney/Renal Fibrosis Treatment Product Table 58. ProMetic Life-Sciences Inc. Revenue in Kidney/Renal Fibrosis Treatment Business (2017-2022) & (US$ Million) Table 59. ProMetic Life-Sciences Inc. Recent Development Table 60. La Jolla Pharmaceutical Company Company Details Table 61. La Jolla Pharmaceutical Company Business Overview Table 62. La Jolla Pharmaceutical Company Kidney/Renal Fibrosis Treatment Product Table 63. La Jolla Pharmaceutical Company Revenue in Kidney/Renal Fibrosis Treatment Business (2017-2022) & (US$ Million) Table 64. La Jolla Pharmaceutical Company Recent Development Table 65. Genzyme Corporation Company Details Table 66. Genzyme Corporation Business Overview Table 67. Genzyme Corporation Kidney/Renal Fibrosis Treatment Product Table 68. Genzyme Corporation Revenue in Kidney/Renal Fibrosis Treatment Business (2017-2022) & (US$ Million) Table 69. Genzyme Corporation Recent Development Table 70. BioLine Rx Ltd Company Details Table 71. BioLine Rx Ltd Business Overview Table 72. BioLine Rx Ltd Kidney/Renal Fibrosis Treatment Product Table 73. BioLine Rx Ltd Revenue in Kidney/Renal Fibrosis Treatment Business (2017-2022) & (US$ Million) Table 74. BioLine Rx Ltd Recent Development Table 75. Research Programs/Design for This Report Table 76. Key Data Information from Secondary Sources Table 77. Key Data Information from Primary Sources List of Figures Figure 1. Kidney/Renal Fibrosis Treatment Product Picture Figure 2. Global Kidney/Renal Fibrosis Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Kidney/Renal Fibrosis Treatment Market Size 2017-2028 (US$ Million) Figure 4. United States Kidney/Renal Fibrosis Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 5. United States Kidney/Renal Fibrosis Treatment Market Size 2017-2028 (US$ Million) Figure 6. United States Kidney/Renal Fibrosis Treatment Market Share in Global 2017-2028 Figure 7. Kidney/Renal Fibrosis Treatment Report Years Considered Figure 8. Product Picture of Angiotensin II Receptor Blockers (ARBs) Figure 9. Product Picture of Angiotensin Converting Enzyme (ACE) Inhibitors Figure 10. Product Picture of Pirfenidone Figure 11. Product Picture of Renin Inhibitors Figure 12. Product Picture of Vasopeptidase Inhibitors Figure 13. Global Kidney/Renal Fibrosis Treatment Market Share by Type in 2022 & 2028 Figure 14. Global Kidney/Renal Fibrosis Treatment Market Size by Type (2017-2028) & (US$ Million) Figure 15. Global Kidney/Renal Fibrosis Treatment Market Share by Type (2017-2028) Figure 16. United States Kidney/Renal Fibrosis Treatment Market Share by Type in 2022 & 2028 Figure 17. United States Kidney/Renal Fibrosis Treatment Market Size by Type (2017-2028) & (US$ Million) Figure 18. United States Kidney/Renal Fibrosis Treatment Market Share by Type (2017-2028) Figure 19. Product Picture of Commercial/Private Hospitals Figure 20. Product Picture of Public Health Hospitals Figure 21. Product Picture of Clinics Figure 22. Product Picture of Home Treatment Figure 23. Global Kidney/Renal Fibrosis Treatment Market Share by Application in 2022 & 2028 Figure 24. Global Kidney/Renal Fibrosis Treatment Market Size by Application (2017-2028) & (US$ Million) Figure 25. Global Kidney/Renal Fibrosis Treatment Market Share by Application (2017-2028) Figure 26. United States Kidney/Renal Fibrosis Treatment Market Share by Application in 2022 & 2028 Figure 27. United States Kidney/Renal Fibrosis Treatment Market Size by Application (2017-2028) & (US$ Million) Figure 28. United States Kidney/Renal Fibrosis Treatment Market Share by Application (2017-2028) Figure 29. North America Kidney/Renal Fibrosis Treatment Market Size Growth Rate 2017-2028 (US$ Million) Figure 30. U.S. Kidney/Renal Fibrosis Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 31. Canada Kidney/Renal Fibrosis Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 32. Europe Kidney/Renal Fibrosis Treatment Market Size Growth Rate 2017-2028 (US$ Million) Figure 33. Germany Kidney/Renal Fibrosis Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 34. France Kidney/Renal Fibrosis Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 35. U.K. Kidney/Renal Fibrosis Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 36. Italy Kidney/Renal Fibrosis Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 37. Russia Kidney/Renal Fibrosis Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 38. Asia-Pacific Kidney/Renal Fibrosis Treatment Market Size Growth Rate 2017-2028 (US$ Million) Figure 39. China Kidney/Renal Fibrosis Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 40. Japan Kidney/Renal Fibrosis Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 41. South Korea Kidney/Renal Fibrosis Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 42. India Kidney/Renal Fibrosis Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 43. Australia Kidney/Renal Fibrosis Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 44. Taiwan Kidney/Renal Fibrosis Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 45. Indonesia Kidney/Renal Fibrosis Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 46. Thailand Kidney/Renal Fibrosis Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 47. Malaysia Kidney/Renal Fibrosis Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 48. Philippines Kidney/Renal Fibrosis Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 49. Latin America Kidney/Renal Fibrosis Treatment Market Size Growth Rate 2017-2028 (US$ Million) Figure 50. Mexico Kidney/Renal Fibrosis Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 51. Brazil Kidney/Renal Fibrosis Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 52. Argentina Kidney/Renal Fibrosis Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 53. Middle East & Africa Kidney/Renal Fibrosis Treatment Market Size Growth Rate 2017-2028 (US$ Million) Figure 54. Turkey Kidney/Renal Fibrosis Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 55. Saudi Arabia Kidney/Renal Fibrosis Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 56. U.A.E Kidney/Renal Fibrosis Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 57. Galectin Therapeutics Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2017-2022) Figure 58. Merck & Co. Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2017-2022) Figure 59. F. Hoffman-La Roche Ltd. Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2017-2022) Figure 60. Pfizer Inc. Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2017-2022) Figure 61. InterMune Inc. Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2017-2022) Figure 62. ProMetic Life-Sciences Inc. Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2017-2022) Figure 63. La Jolla Pharmaceutical Company Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2017-2022) Figure 64. Genzyme Corporation Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2017-2022) Figure 65. BioLine Rx Ltd Revenue Growth Rate in Kidney/Renal Fibrosis Treatment Business (2017-2022) Figure 66. Bottom-up and Top-down Approaches for This Report Figure 67. Data Triangulation Figure 68. Key Executives Interviewed

Galectin Therapeutics Merck & Co. F. Hoffman-La Roche Ltd. Pfizer Inc. InterMune Inc. ProMetic Life-Sciences Inc. La Jolla Pharmaceutical Company Genzyme Corporation BioLine Rx Ltd